Beam Therapeutics (BEAM) announced initial safety and efficacy data from its Phase 1/2 trial of BEAM-302, establishing clinical proof-of-concept as a potential treatment for alpha-1 antitrypsin ...

TD Cowen analyst Bryan Bergin raised the firm’s price target on CI&T to $10 from $9 and keeps a Buy rating on the shares. The firm said its growth outperformance and upbeat tone stand out in an ...

As of March 11 at 3:32:29 PM EDT. Market Open. Loading Chart for CI250314P00302500 ...

As of March 4 at 9:32:32 AM EST. Market Open.

*Estimated payments are calculated by Cars.com and are for informational purposes only. We’ve estimated your taxes based on your provided ZIP code. These estimates do not include title ...

*Estimated payments are calculated by Cars.com and are for informational purposes only. We’ve estimated your taxes based on your provided ZIP code. These estimates do not include title ...

As of February 25 at 2:36:24 p.m. EST. Market Open.

SEC Filings provided by EDGAR Online, Inc.

Copyright © 2025 MarketWatch, Inc. All rights reserved.

Did you know that we deliver to 130 countries or regions and offer a range of delivery options to suit you wherever you are in the world? Find out more Sign up once to our Selfridges+ service and you ...

Branding is not just about designing a logo or choosing attractive colors; it is the process of shaping emotions, memories, and experiences that customers associate with a brand. Take Apple, for ...

This is the metadata section. Skip to content viewer section.